The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 06, 2022
Filed:
Sep. 01, 2020
Applicants:
Board of Regents, the University of Texas System, Austin, TX (US);
Chempartner Corporation, South San Francisco, CA (US);
Inventors:
Maria Emilia Di Francesco, Houston, TX (US);
Philip Jones, Houston, TX (US);
Christopher Lawrence Carroll, Houston, TX (US);
Jason Bryant Cross, Pearland, TX (US);
Suyambu Kesava Vijayan Ramaswamy, Houston, TX (US);
Michael Garrett Johnson, San Francisco, CA (US);
Sarah Lively, San Carlos, CA (US);
David Lapointe, Oakland, CA (US);
Assignees:
Board of Regents, The University of Texas System, Austin, TX (US);
ChemPartner Corporation, South San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/14 (2006.01); C07D 413/04 (2006.01); C07D 411/14 (2006.01); C07D 471/04 (2006.01); C07D 417/14 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07D 411/14 (2013.01); C07D 413/04 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); A61K 2300/00 (2013.01);
Abstract
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.